News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

KAI Pharmaceuticals, Inc. Announces Late Breaker Poster Presentation of KAI-4169 Phase 2 Clinical Results at the American Society of Nephrology’s Kidney Week 2011



11/11/2011 6:46:27 AM

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--KAI Pharmaceuticals, Inc., a privately held drug discovery and development company, today announced that results from the Company’s Phase 2 study of KAI-4169 will be presented in a late breaker poster presentation at the ongoing annual meeting of the American Society of Nephrology (ASN) on Saturday, November 12, 2011.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES